Can a short film get more people vaccinated against HPV?
NCT ID NCT04611022
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing whether an educational video and toolkit can help more people from underserved groups start and finish the HPV vaccine series. The vaccine protects against HPV, a virus that can cause certain cancers. The trial will enroll 1,000 patients and parents at Denver Health, measuring changes in knowledge, intentions, and actual vaccine uptake.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- HPV educational video and toolkit
- What this could lead to
- If successful, this approach could increase HPV vaccination rates in underserved communities, helping prevent HPV-related cancers.
- What could go wrong
- This is a behavioral study, not a drug trial, so results depend on participants' willingness to get vaccinated. It may not work for all groups or settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HUMAN PAPILLOMA VIRUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Colorado Hospital
RECRUITINGDenver, Colorado, 80237, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can the HPV vaccine fully protect transgender women and people with HIV?
- Tweets that tell a story: a new approach to boosting HPV vaccination
- Could HPV shots start earlier? study tests vaccine in kids as young as 4
- Immune cell therapy takes on HPV
- ERs may soon offer At-Home HPV tests to reach women who skip screenings
- Could a common numbing drug help fight throat cancer?